Eli Lilly (LLY)
Latest
-
Worried About Market Volatility? These Are Five of the Safest Vanguard Funds to Own
recession The safest Vanguard funds can help prepare investors for continued market tumult, but without high fees.
By Kyle Woodley Last updated
recession -
Eli Lilly Stock Rises After Profit, Outlook Top Expectations
Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 guidance. Here's what you need to know.
By Joey Solitro Published
-
Stock Market Today: Stocks Are Mixed Ahead of CPI
Cool wholesale inflation numbers provide only slight relief before Wednesday's release of December Consumer Price Index data.
By David Dittman Published
-
Stock Market Today: The S&P 500 Reclaims the 6K Level
Investors see Scott Bessent as a safe shepherd of the economy as the president-elect burnishes his "Tariff Man" reputation.
By David Dittman Published
-
Eli Lilly's Weight-Loss Drugs Fuel Beat-And-Raise Quarter
Eli Lilly stock is surging after the pharma giant beat Q2 estimates and lifted its full-year outlook. Here's what you need to know.
By Joey Solitro Published
-
Stock Market Today: Stocks Rise as Fed Speakers Speak and Nvidia Awaits
Markets eked out gains in a low-volume session that was more focused on upcoming earnings from NVDA.
By Dan Burrows Last updated
-
3M Stock Is Higher Despite Its Dividend Cut. Here's Why
3M is snapping its decades-long streak of dividend hikes, yet it's been one of the best Dow Jones stocks this week. Here's what you need to know.
By Joey Solitro Last updated
-
Eli Lilly Stock Surges on Demand for Weight-Loss Drugs
Eli Lilly beat earnings expectations for the first quarter and raised its outlook for the year.
By Joey Solitro Published
-
Stock Market Today: Stocks End Mixed After Disappointing Economic Data
The main indexes made muted moves Tuesday as investors took data that showed a big drop in durable goods and consumer confidence.
By Karee Venema Published